PT  - JOURNAL ARTICLE
AU  - Cerci, Juliano
AU  - Pereira, Carlos
AU  - Vitola, Joao
TI  - Feasibility of biopsy guided by FDG-PET/CT in oncological patients
DP  - 2011 May 01
TA  - Journal of Nuclear Medicine
PG  - 1791--1791
VI  - 52
IP  - supplement 1
4099  - http://jnm.snmjournals.org/content/52/supplement_1/1791.short
4100  - http://jnm.snmjournals.org/content/52/supplement_1/1791.full
SO  - J Nucl Med2011 May 01; 52
AB  - 1791 Objectives When implying institution of therapy, FDG-PET/CT positive results should be confirmed by histology whenever possible. We evaluated the feasibility of percutaneous PET/CT-guided biopsies to histological confirmation of PET/CT positive lesions. Methods We prospectively evaluated 15 patients who underwent PET/CT guided biopsies. Technical feasibility and clinical success rates of PET/CT-guided biopsies were evaluated. Results Patients with FDG-PET/CT suspected lesions of lymphoma, melanoma, breast cancer and non-small cell lung cancer were admitted for biopsy guided by FDG-PET/CT. PET/CT positive lesions were successfully accessed and representative tissue samples were obtained in all patients. No complications or adverse effects occurred. Histological confirmation of cancer was obtained in 10/15 patients. Conclusions PET-CT guided biopsy is feasible and may optimize the diagnostic yield of imagine guided interventions. Also, PET/CT positive lesions with no morphological correlation may now be accessible to percutaneous interventions